Vectors, cell lines and their use in obtaining extended episomal maintenance replication of hybrid plasmids and expression of gene products

Details for Australian Patent Application No. 2006212393 (hide)

Owner Icosagen Cell Factory Ou

Inventors Ustav, Ene; Mandel, Tiiu; Abroi, Aare; Tagen, Ingrid; Ustav, Mart; Silla, Toomas; Geimanen, Jelizaveta; Janikson, Kadri

Agent Callinan

Pub. Number AU-B-2006212393

PCT Pub. Number WO2006/084754

Priority 60/652,390 11.02.05 US

Filing date 13 February 2006

Wipo publication date 17 August 2006

Acceptance publication date 7 July 2011

International Classifications

C12N 15/86 (2006.01) Mutation or genetic engineering - Viral vectors

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

Event Publications

2 August 2007 PCT application entered the National Phase

  PCT publication WO2006/084754 Priority application(s): WO2006/084754

20 December 2007 Alteration of Name

  The name of the applicant has been altered to Quattromed Cell Factory OU

12 May 2011 Alteration of Name

  The name of the applicant has been altered to Icosagen Cell Factory Ou

7 July 2011 Application Accepted

  Published as AU-B-2006212393

3 November 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006212397-Process for the preparation of intermediates

2006212392-Method for isolating nucleic acids, the nucleic acids being immobilised on a matrix at an increased temperature